These effects, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two assist the strategy of focusing on ACKR3 as a unique strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-link